Clinical applications of probiotic agents

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Nonpathogenic bacteria in the intestinal lumen have known beneficial roles.
• Recent research highlights clinical benefits of ingesting specific nonpathogenic organisms, termed probiotics.
• Emerging literature suggests potential benefits of modifying gut flora in high-risk groups like premature infants and children on antibiotics.

Purpose of the Study:

• To review the emerging evidence for clinical benefits of probiotics.
• To explore the potential mechanisms of action, possibly involving the gut's immunologic functions.
• To identify factors influencing probiotic efficacy and areas needing further investigation.

Main Methods:

• Literature review of studies on probiotic use.
• Analysis of research on prophylactic and therapeutic benefits in conditions like viral gastroenteritis and atopic disease.
• Examination of factors affecting probiotic efficacy, including dose, host characteristics, and microbial environment.

Main Results:

• Probiotics demonstrate potential prophylactic and therapeutic benefits.
• Mechanisms of action may involve interactions with the gut as an immunologic organ.
• Documented benefits vary and depend on multiple factors, including the specific probiotic agent, dose, and host factors.

Conclusions:

• Careful documentation of safety, specification, and delivery methods is crucial before widespread probiotic recommendations.
• Further cost-benefit assessments are needed for incorporating probiotics into diets for prevention or treatment.
• Improved regulation of commercial probiotic products is necessary.